ORIGINAL
ARTICLE |
Background: Chronic alcoholics are
known to have dyslipidemia, which can aggravate organ dysfunction along
with increased oxidative stress due to alcohol metabolism. We are
studying the impact of Antabuse treatment in reversing the damages
caused by chronic alcoholism at metabolite level.
Results: This is hospital based
cross sectional case control study, with 34 chronic alcoholic patients
and 20 Antabuse treated patient for alcoholism. The mean plasma MDA
(oxidative stress marker) level among the chronic alcoholics was 12.3 ±
4.3 µmol/L and in Antabuse treated group was 2.8 ± 0.3 µmol/L. Chronic
alcoholic group had significantly elevated lipid profile then Antabuse
treated group suggesting dyslipidemia in alcoholic group in our study
population.
Discussion: We observed
positive correlation between oxidative stress marker and Lipid profile.
Dyslipidemia and oxidative stress levels were significantly lower in
Antabuse treated patients suggesting early treatment of such addicts
and complete abstinence from consumption showed reversal of the
metabolic derangement caused by chronic alcoholism.